Myasthenia Gravis Foundation of America Global MG Patient Registry
NCT06617741 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 3800
Last updated 2024-09-27
Summary
The goal of this observational study is to learn about the experiences of people living with Myasthenia Gravis (MG) in the United States. The main questions it aims to answer are:
* How and when are people with MG diagnosed?
* What are the most common symptoms associated with MG?
* What treatments are being used to treat MG?
* What are the impacts of MG on activities of daily living, employment and quality of life?
* What are the experiences with exacerbation, hospitalization and healthcare access for people with MG? Participants will answer a survey to enroll in the study, and be invited to fill out an update survey twice a year.
Conditions
- Myasthaenia Gravis
- Myasthenia
- Myasthenia Gravis Associated with Thymoma
- Myasthenia Gravis Crisis
- Myasthenia Gravis Exacerbations
- Myasthenia Gravis Generalised
- Myasthenia Gravis with Exacerbation (Disorder)
- Myasthenia Gravis, Adult Form
- Myasthenia Gravis, Generalized
- Myasthenia Gravis, Ocular
- Myasthenia Gravis, Thymectomy
- Myasthenia Gravis
- Myasthenia Gravis, MuSK
Sponsors & Collaborators
-
Alira Health
collaborator OTHER -
Myasthenia Gravis Foundation of America
lead OTHER
Principal Investigators
-
Patient Registry PI · Yale University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-10-12
- Primary Completion
- 2029-09-19
- Completion
- 2029-09-19
Countries
- United States
Study Locations
More Related Trials
-
A Study in Patients With Myasthenia Gravis in China
NCT06700616 ·Status: ACTIVE_NOT_RECRUITING
-
TheRapeutic Effect of Different immunosuppressAnts on Non-Thymoma Ocular Myasthenia Gravis: a Real-world Study
NCT04182984 ·Status: RECRUITING
-
A Prospective Cohort Study Of Myasthenia Gravis
NCT04674605 ·Status: UNKNOWN
-
Immune Profiles in Myasthenia Gravis
NCT05095103 ·Status: UNKNOWN
-
Safety and Efficacy Study of Eculizumab in Patients With Refractory Generalized Myasthenia Gravis
NCT00727194 ·Status: TERMINATED ·Phase: PHASE2
-
A Study to Evaluate the Clinical Outcomes of Efgartigimod PH20 SC in Adults With New-onset Generalized Myasthenia Gravis (gMG)
NCT06909214 ·Status: RECRUITING ·Phase: PHASE4
-
Help Build an A.I. Model to Predict Myasthenia Gravis Symptom Patterns and Flares
NCT04590716 ·Status: COMPLETED
-
Efficacy of Methotrexate in Myasthenia Gravis
NCT00814138 ·Status: COMPLETED ·Phase: PHASE2
-
Expediting Myasthenia Gravis (MG) Diagnostic Evaluation: A Novel, Proof-of-Concept for Undiagnosed, Symptomatic Patients That Uses Social Media Targeting and Self-Assessment
NCT06381284 ·Status: COMPLETED
-
The EXPLORE MG Registry for Myasthenia Gravis
NCT03792659 ·Status: RECRUITING
-
A Prospective Cohort Study of Myasthenia Gravis in China
NCT06006832 ·Status: RECRUITING
-
Clinical and Laboratory Profile of Myasthenia Gravis in Children At Sohag University Hospitals
NCT06774937 ·Status: NOT_YET_RECRUITING
-
PPDTM CorEvitasTM Myasthenia Gravis (MG) Drug Safety and Effectiveness Registry
NCT07217509 ·Status: ENROLLING_BY_INVITATION
-
PK, PD, Safety, and Efficacy Study of Gefurulimab in Pediatric Patients With AChR+ Generalized Myasthenia Gravis
NCT06607627 ·Status: RECRUITING ·Phase: PHASE3
-
Hematopoietic Stem Cell Therapy for Patients With Refractory Myasthenia Gravis
NCT00424489 ·Status: TERMINATED ·Phase: PHASE1
-
Disease-Modifying Treatments for Myasthenia Gravis
NCT03490539 ·Status: COMPLETED
-
Acupuncture in Myasthenia Gravis (AcuMG)
NCT05230082 ·Status: COMPLETED ·Phase: NA
-
The Evaluation of Belimumab in Myasthenia Gravis (MG)
NCT01480596 ·Status: COMPLETED ·Phase: PHASE2
-
A Pilot Trial of Rituxan in Refractory Myasthenia Gravis
NCT00619671 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Variables Predicting Reintubation After Thymectomy in Patients With Myasthenia Gravis
NCT03597373 ·Status: UNKNOWN
-
Biomarkers for Fatigue in Patients with Myasthenia Gravis
NCT06860347 ·Status: COMPLETED
-
Tissue Repository for Studies of Myasthenia Gravis
NCT02902536 ·Status: COMPLETED
-
Clinical Prognosis and Progression of Myasthenia Gravis Patients
NCT04101578 ·Status: UNKNOWN
-
A Pilot Study to Explore the Role of Gut Flora in Myasthenia Gravis
NCT04224506 ·Status: WITHDRAWN
-
A Phase 3 Study to Evaluate the Efficacy and Safety of Efgartigimod IV in Patients With Acetylcholine Receptor Binding Antibody Seronegative Generalized Myasthenia Gravis
NCT06298552 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3